Firefly Neuroscience, Inc.
PublicFirefly Neuroscience, Inc. is now publicly traded
The data on this page reflects Firefly Neuroscience, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Follow-on Offering
Mar 8, 2026
Total Funding Raised
$2.25M
Company Overview
Firefly Neuroscience, Inc. is a medical technology and AI company that provides an FDA-cleared Brain Network Analytics (BNA™) software platform to improve outcomes for patients with mental illnesses and neurological disorders.
AI Layer
Application
Keywords
Firefly Neuroscience, Inc. Comparables
Compare Firefly Neuroscience, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroVigil, Inc. | 78% | |
| Mentis Cura | 74% | |
| Vistim Labs | 74% |
Firefly Neuroscience, Inc. Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Recent news
Latest coverage and updates
- partners_withSep 25, 2026
On Sep 25th '26, Firefly Neuroscience, Inc. and NeuroSigma, Inc. announce a strategic partnership to introduce the Monarch eTNS System to Firefly Neuroscience, Inc.'s nationwide Evoke clinician network and support clinician education.
- partners_withSep 17, 2026
On Sep 17th '26 in New York, Firefly Neuroscience, Inc. and Radial Health, Inc. enter a strategic collaboration to pursue integrating AI-powered brain-function measures into diagnostic processes, treatment-pathway identification, care coordination, and outcome tracking.
Firefly Neuroscience, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access